Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Pharma's Social Media Working Group: Who It Consists of, How It Formed, and What Its Objectives Are

  • Broadcast in Business
Pharmaguy

Pharmaguy

×  

Follow This Show

If you liked this show, you should follow Pharmaguy.
h:755
s:899082
archived
A conversation with Craig M. Audet, Vice-President and Head of the US Regulatory Affairs Marketed Products Group at sanofi-aventis, Mark Gaydos, Senior Director, U.S. Regulatory Affairs Marketed Products at sanofi-aventis, and Cindy Phillips, Sr Dir Labeling and Promotional Compliance at Millennium Pharmaceuticals, about their views on how pharmaceutical companies should handle posts made on social media sites owned or sponsored by them. Of particular interest are posts that mention off-label indications or adverse events.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled